USD 55.77
Price
3.11
(5.91%)
Day Change
|
|
---|
BMY, the overall quality is not good (Quality = 38) but the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
Quality Factors |
|
38% |
Timing Factors |
|
57% |
Financial Health |
|
50% |
Key Statistics |
|
66% |
Return to Investors |
|
33% |
Registration Details |
Analyze Date | 2024-10-31 20:16:24 |
Symbol | BMY |
Name | BRISTOL-MYERS SQUIBB COMPANY |
Sector | Healthcare >> Drug Manufacturers - General |
Market | NYSE |
Listed Shares | 2,027.40 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 106,762.88 / 229,809.10 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |